Tag Archives: Israeli companies

A Guide to Understanding Anti-Assignment Clauses

Introduction With the increasing trend of globalization in the business world, Israeli companies and investors are commonly entering into agreements with U.S.-based entities. One of the most frequently found clauses in U.S. commercial agreements is an anti-assignment provision that prevents either or both of the parties from assigning the agreement to a third party prior … Continue Reading

How Israeli entities can plan for US security review and reduce risk when investing in US technology companies

Despite the close US-Israel relationship, Israeli companies and funds seeking to invest in US technologies can face US national security scrutiny that could significantly delay deals, and in some cases prevent or unwind the transaction. Israeli investment in US technology companies, however, should continue to be regarded as an attractive option, as long as the … Continue Reading

Greenberg Traurig Tel Aviv and Shanghai Offices Sponsor the First Ever China-Israel Technology, Innovation and Investment Summit

Earlier this month, the first ever China-Israel Technology, Innovation and Investment Summit, jointly sponsored by the Greenberg Traurig Tel Aviv and Shanghai offices, took place in Beijing. The 3-day event was organized by the Israeli and Chinese governments, together with Infinity Group, an investment firm that has been involved in the China-Israel ecosystem for more … Continue Reading

Important Developments in the Area of Native Advertising

With Start-Up Nation continuing to play a leadership role within the global ad-tech ecosystem, both on the technology and strategy fronts, it is critical that its players understand the changing dynamics occurring within the world’s largest consumer market – i.e., the U.S., especially on the regulatory front. The most recent and notable directive on advertising … Continue Reading

GT Events during the 2016 JPMorgan Healthcare Conference & the 9th Annual OneMedForum in San Francisco

Innovation and progress are core ingredients in today’s financial ecosystem, especially in the fields of health care and life sciences.  Greenberg Traurig has a renowned healthcare practice, serving many clients in Israel and abroad.  Greenberg Traurig will be hosting two events in January during the 2016 JPMorgan Healthcare Conference and the 9th Annual OneMedForum in … Continue Reading

A Conversation with Alan Dershowitz and Jay Lefkowitz about U.S. & Israeli Relations

GT had the honor to sponsor a recent Philadelphia event “A Conversation with and Jay Lefkowitz about U.S. & Israeli Relations”. The event, honoring GT client TEVA Pharmaceuticals USA, was attended by GT Philadelphia shareholder Bob Goldich and Israel Practice member, Beth Cohen. GT Israel practice co-chair Bob Grossman and other GT lawyers represent TEVA … Continue Reading

SEC Adopts Regulation Crowdfunding to Facilitate Early Capital Raises

The U.S. regulators have long been considering ways to make it easier for early-stage startup companies to raise capital in a more flexible and less cumbersome method.  The SEC has finally published regulations providing emerging companies with access to U.S. “crowd” investors making smaller investments.  Although the new regulations are perhaps less of a radical … Continue Reading

Government Grants Now Available to Israeli Companies Establishing Marketing Representatives in China and Japan

Earlier this month, Israel’s Ministry of Economy’s Foreign Trade Administration announced a new assistance program for Israeli companies wishing to establish marketing representatives in, among other countries, China and Japan. The purpose of the program is twofold: both to accelerate rapid economic growth of Israeli companies in the target countries, as well as diversification of … Continue Reading

Greenberg Traurig Assists Israeli Company in Raising Capital in the US

Joining a number of companies listed on the Tel Aviv Stock Exchange that also have recently been listed for trading in the United States through American Depository Receipts (ADRs) is universal flu vaccine developer BiondVax Pharmaceuticals Ltd. The company raised $10 million on Nasdaq at a price of $5.01 per American Depositary Share (ADS). ADRs are … Continue Reading

Greenberg Traurig to Host Presentation: ‘Trends in the Israeli Life Sciences Arena’

Greenberg Traurig’s Boston office will be hosting a breakfast presentation entitled “Trends in the Israeli Life Sciences Arena” featuring guest speaker Elka Nir from Israel.  The event is scheduled for 8-9:45 a.m. on Friday, April 24, 2015, with welcome remarks at 8:30 a.m. by David Dykeman, co-chair of Greenberg Traurig’s Life Sciences & Medical Technology Group, … Continue Reading
LexBlog